These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3301161

  • 21. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.
    Bogardus C, Lillioja S, Howard BV, Reaven G, Mott D.
    J Clin Invest; 1984 Oct; 74(4):1238-46. PubMed ID: 6384267
    [Abstract] [Full Text] [Related]

  • 22. Serum C-peptide concentrations and their value in evaluating the usefulness of insulin therapy in elderly diabetics.
    Kyllästinen M, Elfving S.
    Gerontology; 1986 Oct; 32(6):317-26. PubMed ID: 3556328
    [Abstract] [Full Text] [Related]

  • 23. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE, Matthews DR.
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [Abstract] [Full Text] [Related]

  • 24. Plasma-lipids and glucose/insulin relationship in non-insulin-requiring diabetics with and without retinopathy.
    Kissebah AH, Kohner EM, Lewis B, Siddiq YK, Lowy C, Fraser TR.
    Lancet; 1975 May 17; 1(7916):1104-8. PubMed ID: 49469
    [Abstract] [Full Text] [Related]

  • 25. [C-peptide determination in diabetics for the evaluation of insulin requirements].
    Keller U, Pasquel M, Berger W.
    Schweiz Med Wochenschr; 1987 Feb 07; 117(6):187-92. PubMed ID: 3551060
    [Abstract] [Full Text] [Related]

  • 26. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS, Draeger KE, van Iperen AM, Martini C, Aarsen M, Heine RJ.
    Diabet Med; 1997 Jul 07; 14(7):556-63. PubMed ID: 9223393
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Control of non-insulin dependent diabetes is not correlated with endogenous insulin secretion.
    Lev-Ran A, Hwang D, Barseghian G, Hill LR.
    Diabete Metab; 1986 Dec 07; 12(6):325-8. PubMed ID: 3545932
    [Abstract] [Full Text] [Related]

  • 29. High-carbohydrate, low-fat diet: effect on lipid and carbohydrate metabolism, GIP and insulin secretion in diabetics.
    Sestoft L, Krarup T, Palmvig B, Meinertz H, Faergeman O.
    Dan Med Bull; 1985 Mar 07; 32(1):64-9. PubMed ID: 3886310
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Stabilizing effect of exenatide in a patient with C-peptide-negative diabetes mellitus.
    Paisley AN, Savage MW, Wiles PG.
    Diabet Med; 2009 Sep 07; 26(9):935-8. PubMed ID: 19719716
    [Abstract] [Full Text] [Related]

  • 32. Community care for elderly diabetics: the Fredericia Survey of diabetic and fasting hyperglycaemic subjects aged 60-74 years.
    Damsgaard EM, Frøland A.
    Dan Med Bull; 1989 Dec 07; 36(6):565-8. PubMed ID: 2612225
    [Abstract] [Full Text] [Related]

  • 33. Human C-peptide in normal and diabetic subjects.
    Heding LG, Rasmussen SM.
    Diabetologia; 1975 Jun 07; 11(3):201-6. PubMed ID: 1149953
    [Abstract] [Full Text] [Related]

  • 34. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
    Ubukata E.
    Ann Nutr Metab; 1990 Jun 07; 34(6):333-42. PubMed ID: 2076025
    [Abstract] [Full Text] [Related]

  • 35. Glucose and insulin secretory response patterns following diet and tolazamide therapy in diabetes.
    Turtle JR.
    Br Med J; 1970 Sep 12; 3(5723):606-10. PubMed ID: 5470087
    [Abstract] [Full Text] [Related]

  • 36. Effect of exposure to non-esterified fatty acid on progressive deterioration of insulin secretion in patients with Type 2 diabetes: a long-term follow-up study.
    Morita S, Shimajiri Y, Sakagashira S, Furuta M, Sanke T.
    Diabet Med; 2012 Aug 12; 29(8):980-5. PubMed ID: 22221293
    [Abstract] [Full Text] [Related]

  • 37. Insulin secretory capacity in Singapore diabetic subjects.
    Thai AC, Yeo PP, Chan L, Wang KW, Lui KF, Cheah JS, Tan BY.
    Ann Acad Med Singap; 1985 Apr 12; 14(2):191-3. PubMed ID: 3898977
    [Abstract] [Full Text] [Related]

  • 38. The relationship between residual insulin secretion and metabolic stability in type 1 (insulin dependent) diabetes.
    Lutterman JA, Benraad TJ, van 't Laar A.
    Diabetologia; 1981 Aug 12; 21(2):99-102. PubMed ID: 7021291
    [Abstract] [Full Text] [Related]

  • 39. Ramadan fasting and non-insulin-dependent diabetes: effect on metabolic control.
    Laajam MA.
    East Afr Med J; 1990 Oct 12; 67(10):732-6. PubMed ID: 2282897
    [Abstract] [Full Text] [Related]

  • 40. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
    Choudhary P, Lonnen K, Emery CJ, MacDonald IA, MacLeod KM, Amiel SA, Heller SR.
    Diabet Med; 2009 Jul 12; 26(7):665-72. PubMed ID: 19573114
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.